Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Pulmonary Arterial Hypertension
NCT01352026Phase 2Withdrawn
- Sponsor
- CHU de Nantes
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of metformin in pulmonary arterial hypertension (PAH), sponsored by CHU de Nantes. Primary endpoint: 6-minute walk test distance. Planned start May 2011; status: withdrawn.
02
Drugs
metformin
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01352026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01352026.